scispace - formally typeset
G

Gregory Y Lauwers

Researcher at Harvard University

Publications -  10
Citations -  4263

Gregory Y Lauwers is an academic researcher from Harvard University. The author has contributed to research in topics: Barrett's esophagus & Endoscopic mucosal resection. The author has an hindex of 9, co-authored 10 publications receiving 4170 citations.

Papers
More filters
Journal ArticleDOI

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

TL;DR: It is shown that a single infusion of the VEGF-specific antibody bevacizumab decreases tumor perfusion, vascular volume, microvascular density, interstitial fluid pressure and the number of viable, circulating endothelial and progenitor cells, and increases the fraction of vessels with pericyte coverage in rectal carcinoma patients.
Journal Article

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

TL;DR: In this article, a single infusion of the VEGF-specific antibody bevacizumab decreases tumor perfusion, vascular volume, microvascular density, interstitial fluid pressure and the number of viable, circulating endothelial and progenitor cells, and increases the fraction of vessels with pericyte coverage in rectal carcinoma patients.
Journal ArticleDOI

Endoscopic mucosal resection: an improved diagnostic procedure for early gastroesophageal epithelial neoplasms.

TL;DR: Endoscopic mucosal resection can substantially modify the diagnostic grade of a lesion and therefore facilitate optimal therapeutic decisions by avoiding undertreatment and overtreatment based on inaccurate grading and staging, and is superior to biopsy for diagnosing superficial gastroesophageal tumors.
Journal ArticleDOI

EUS-guided photodynamic therapy of the pancreas: a pilot study

TL;DR: EUS-guided photodynamic therapy is a safe and simple technique that can induce small areas of focal tissue ablation within the liver, the pancreas, the kidney, and the spleen, and potentially could be used to treat a variety of benign and malignant conditions.
Journal ArticleDOI

Management of superficial Barrett's epithelium-related neoplasms by endoscopic mucosal resection: clinicopathologic analysis of 27 cases.

TL;DR: It is observed that EMR offers improved diagnosis and staging as compared with biopsy and EUS, a significant advantage since it can modify patients' management, however, frequent incompleteness of resection and high persistence/recurrence are significant pitfalls that dictate continued endoscopic surveillance.